HEADER LIGASE 29-JUL-08 3DZ7 TITLE HUMAN ADOMETDC WITH 5'-[(CARBOXAMIDOMETHYL)METHYLAMINO]-5'-DEOXY-8- TITLE 2 METHYLADENOSINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN; COMPND 3 CHAIN: B; COMPND 4 SYNONYM: ADOMETDC, SAMDC, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA COMPND 5 CHAIN; COMPND 6 EC: 4.1.1.50; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN; COMPND 10 CHAIN: A; COMPND 11 SYNONYM: ADOMETDC, SAMDC, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA COMPND 12 CHAIN; COMPND 13 EC: 4.1.1.50; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AMD1, AMD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PQE30; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: AMD1, AMD; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PQE30 KEYWDS COMPLEXES OF ADOMETDC WITH 8-SUBSTITUTED LIGANDS, DECARBOXYLASE, KEYWDS 2 LYASE, PYRUVATE, S-ADENOSYL-L-METHIONINE, SPERMIDINE BIOSYNTHESIS, KEYWDS 3 ZYMOGEN, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR S.BALE,D.E.MCCLOSKEY,A.E.PEGG,J.A.SECRIST III,W.C.GUIDA,S.E.EALICK REVDAT 5 15-NOV-23 3DZ7 1 LINK ATOM REVDAT 4 30-AUG-23 3DZ7 1 REMARK SEQADV LINK REVDAT 3 25-OCT-17 3DZ7 1 REMARK REVDAT 2 12-JAN-10 3DZ7 1 JRNL REVDAT 1 10-MAR-09 3DZ7 0 JRNL AUTH D.E.MCCLOSKEY,S.BALE,J.A.SECRIST III,A.TIWARI,T.H.MOSS III, JRNL AUTH 2 J.VALIYAVEETTIL,W.H.BROOKS,W.C.GUIDA,A.E.PEGG,S.E.EALICK JRNL TITL NEW INSIGHTS INTO THE DESIGN OF INHIBITORS OF HUMAN JRNL TITL 2 S-ADENOSYLMETHIONINE DECARBOXYLASE: STUDIES OF ADENINE C8 JRNL TITL 3 SUBSTITUTION IN STRUCTURAL ANALOGUES OF S-ADENOSYLMETHIONINE JRNL REF J.MED.CHEM. V. 52 1388 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19209891 JRNL DOI 10.1021/JM801126A REMARK 2 REMARK 2 RESOLUTION. 1.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 139731.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 24777 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1191 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.91 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3376 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE : 0.2430 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 174 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2459 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 212 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.18000 REMARK 3 B22 (A**2) : -2.68000 REMARK 3 B33 (A**2) : -8.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.05000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.22 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.530 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.390 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.180 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.170 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.230 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 36.76 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN.PARAM REMARK 3 PARAMETER FILE 2 : PYRUVOYL.PARAM REMARK 3 PARAMETER FILE 3 : MAM.PARAM REMARK 3 PARAMETER FILE 4 : WATER.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : PYRUVOYL.TOP REMARK 3 TOPOLOGY FILE 3 : MAM.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3DZ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000048673. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24777 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : 0.07600 REMARK 200 FOR THE DATA SET : 16.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : 0.25000 REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1I7B.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 8000, 100 MM TRIS, 10 MM DTT, REMARK 280 PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.82300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.37600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.82300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.37600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 444 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 483 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 ALA B 3 REMARK 465 ASP B 24 REMARK 465 ALA B 25 REMARK 465 ASN B 26 REMARK 465 PRO A 165 REMARK 465 GLU A 166 REMARK 465 SER A 167 REMARK 465 ARG A 168 REMARK 465 VAL A 169 REMARK 465 ILE A 170 REMARK 465 SER A 171 REMARK 465 GLN A 172 REMARK 465 ARG A 293 REMARK 465 THR A 294 REMARK 465 VAL A 295 REMARK 465 LEU A 296 REMARK 465 ALA A 297 REMARK 465 SER A 298 REMARK 465 PRO A 299 REMARK 465 GLN A 300 REMARK 465 LYS A 301 REMARK 465 LYS A 328 REMARK 465 GLN A 329 REMARK 465 GLN A 330 REMARK 465 GLN A 331 REMARK 465 GLN A 332 REMARK 465 GLN A 333 REMARK 465 SER A 334 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 23 C - N - CD ANGL. DEV. = -18.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 22 46.15 75.74 REMARK 500 GLN B 48 38.89 75.34 REMARK 500 CYS A 82 -157.02 -126.71 REMARK 500 LEU A 86 69.54 -102.37 REMARK 500 PRO A 126 31.05 -94.44 REMARK 500 SER A 154 -140.85 -140.24 REMARK 500 PHE A 250 41.71 -162.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PYR A 68 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PUT B 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE O8M A 368 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JEN RELATED DB: PDB REMARK 900 RELATED ID: 1I72 RELATED DB: PDB REMARK 900 RELATED ID: 1I7B RELATED DB: PDB REMARK 900 RELATED ID: 1I7C RELATED DB: PDB REMARK 900 RELATED ID: 1I7M RELATED DB: PDB REMARK 900 RELATED ID: 1I79 RELATED DB: PDB REMARK 900 RELATED ID: 3DZ2 RELATED DB: PDB REMARK 900 RELATED ID: 3DZ3 RELATED DB: PDB REMARK 900 RELATED ID: 3DZ4 RELATED DB: PDB REMARK 900 RELATED ID: 3DZ5 RELATED DB: PDB REMARK 900 RELATED ID: 3DZ6 RELATED DB: PDB DBREF 3DZ7 B 1 67 UNP P17707 DCAM_HUMAN 1 67 DBREF 3DZ7 A 69 334 UNP P17707 DCAM_HUMAN 69 334 SEQADV 3DZ7 PYR A 68 UNP P17707 INSERTION SEQRES 1 B 67 MET GLU ALA ALA HIS PHE PHE GLU GLY THR GLU LYS LEU SEQRES 2 B 67 LEU GLU VAL TRP PHE SER ARG GLN GLN PRO ASP ALA ASN SEQRES 3 B 67 GLN GLY SER GLY ASP LEU ARG THR ILE PRO ARG SER GLU SEQRES 4 B 67 TRP ASP ILE LEU LEU LYS ASP VAL GLN CYS SER ILE ILE SEQRES 5 B 67 SER VAL THR LYS THR ASP LYS GLN GLU ALA TYR VAL LEU SEQRES 6 B 67 SER GLU SEQRES 1 A 267 PYR SER MET PHE VAL SER LYS ARG ARG PHE ILE LEU LYS SEQRES 2 A 267 THR CYS GLY THR THR LEU LEU LEU LYS ALA LEU VAL PRO SEQRES 3 A 267 LEU LEU LYS LEU ALA ARG ASP TYR SER GLY PHE ASP SER SEQRES 4 A 267 ILE GLN SER PHE PHE TYR SER ARG LYS ASN PHE MET LYS SEQRES 5 A 267 PRO SER HIS GLN GLY TYR PRO HIS ARG ASN PHE GLN GLU SEQRES 6 A 267 GLU ILE GLU PHE LEU ASN ALA ILE PHE PRO ASN GLY ALA SEQRES 7 A 267 ALA TYR CYS MET GLY ARG MET ASN SER ASP CYS TRP TYR SEQRES 8 A 267 LEU TYR THR LEU ASP PHE PRO GLU SER ARG VAL ILE SER SEQRES 9 A 267 GLN PRO ASP GLN THR LEU GLU ILE LEU MET SER GLU LEU SEQRES 10 A 267 ASP PRO ALA VAL MET ASP GLN PHE TYR MET LYS ASP GLY SEQRES 11 A 267 VAL THR ALA LYS ASP VAL THR ARG GLU SER GLY ILE ARG SEQRES 12 A 267 ASP LEU ILE PRO GLY SER VAL ILE ASP ALA THR MET PHE SEQRES 13 A 267 ASN PRO CYS GLY TYR SER MET ASN GLY MET LYS SER ASP SEQRES 14 A 267 GLY THR TYR TRP THR ILE HIS ILE THR PRO GLU PRO GLU SEQRES 15 A 267 PHE SER TYR VAL SER PHE GLU THR ASN LEU SER GLN THR SEQRES 16 A 267 SER TYR ASP ASP LEU ILE ARG LYS VAL VAL GLU VAL PHE SEQRES 17 A 267 LYS PRO GLY LYS PHE VAL THR THR LEU PHE VAL ASN GLN SEQRES 18 A 267 SER SER LYS CYS ARG THR VAL LEU ALA SER PRO GLN LYS SEQRES 19 A 267 ILE GLU GLY PHE LYS ARG LEU ASP CYS GLN SER ALA MET SEQRES 20 A 267 PHE ASN ASP TYR ASN PHE VAL PHE THR SER PHE ALA LYS SEQRES 21 A 267 LYS GLN GLN GLN GLN GLN SER HET PYR A 68 5 HET PUT B 350 6 HET O8M A 368 25 HETNAM PYR PYRUVIC ACID HETNAM PUT 1,4-DIAMINOBUTANE HETNAM O8M 2-[{[(2R,3S,4R,5R)-5-(6-AMINO-8-METHYL-9H-PURIN-9-YL)- HETNAM 2 O8M 3,4-DIHYDROXYTETRAHYDROFURAN-2-YL]METHYL}(METHYL) HETNAM 3 O8M AMINO]ACETAMIDE HETSYN PUT PUTRESCINE HETSYN O8M 5'-[(CARBOXAMIDOMETHYL)METHYLAMINO]-5'-DEOXY-8- HETSYN 2 O8M METHYLADENOSINE FORMUL 2 PYR C3 H4 O3 FORMUL 3 PUT C4 H12 N2 FORMUL 4 O8M C14 H21 N7 O4 FORMUL 5 HOH *212(H2 O) HELIX 1 1 ASP B 31 ILE B 35 5 5 HELIX 2 2 PRO B 36 GLN B 48 1 13 HELIX 3 3 LEU A 86 LYS A 89 5 4 HELIX 4 4 ALA A 90 GLY A 103 1 14 HELIX 5 5 LYS A 119 GLN A 123 5 5 HELIX 6 6 ASN A 129 ALA A 139 1 11 HELIX 7 7 ASP A 185 GLN A 191 1 7 HELIX 8 8 THR A 199 SER A 207 1 9 HELIX 9 9 ILE A 209 ILE A 213 5 5 HELIX 10 10 TYR A 264 LYS A 276 1 13 SHEET 1 A 8 SER B 50 LYS B 56 0 SHEET 2 A 8 GLN B 60 SER B 66 -1 O ALA B 62 N THR B 55 SHEET 3 A 8 MET A 70 SER A 73 -1 O VAL A 72 N GLU B 61 SHEET 4 A 8 ARG A 76 THR A 81 -1 O ILE A 78 N PHE A 71 SHEET 5 A 8 LYS B 12 SER B 19 -1 N LYS B 12 O THR A 81 SHEET 6 A 8 SER A 106 LYS A 115 -1 O SER A 109 N TRP B 17 SHEET 7 A 8 CYS A 156 LEU A 162 -1 O TYR A 158 N ARG A 114 SHEET 8 A 8 GLY A 144 GLY A 150 -1 N MET A 149 O TRP A 157 SHEET 1 B 8 VAL A 217 MET A 222 0 SHEET 2 B 8 TYR A 228 MET A 233 -1 O SER A 229 N THR A 221 SHEET 3 B 8 TYR A 239 THR A 245 -1 O ILE A 244 N TYR A 228 SHEET 4 B 8 TYR A 252 THR A 257 -1 O TYR A 252 N THR A 245 SHEET 5 B 8 GLN A 175 SER A 182 -1 N MET A 181 O VAL A 253 SHEET 6 B 8 LYS A 279 ASN A 287 -1 O LYS A 279 N SER A 182 SHEET 7 B 8 TYR A 318 ALA A 326 -1 O PHE A 325 N PHE A 280 SHEET 8 B 8 LYS A 306 MET A 314 -1 N GLN A 311 O PHE A 322 LINK C PYR A 68 N SER A 69 1555 1555 1.33 CISPEP 1 TYR A 125 PRO A 126 0 0.09 CISPEP 2 ASN A 224 PRO A 225 0 0.36 SITE 1 AC1 5 SER A 69 LYS A 80 THR A 81 HIS A 243 SITE 2 AC1 5 LEU B 65 SITE 1 AC2 8 PHE A 111 ASP A 174 THR A 176 HOH A 448 SITE 2 AC2 8 HOH A 485 LEU B 13 GLU B 15 HOH B 361 SITE 1 AC3 17 CYS A 82 PHE A 223 ASN A 224 CYS A 226 SITE 2 AC3 17 GLY A 227 TYR A 228 SER A 229 HIS A 243 SITE 3 AC3 17 ILE A 244 THR A 245 PRO A 246 GLU A 247 SITE 4 AC3 17 HOH A 380 HOH A 438 PHE B 7 SER B 66 SITE 5 AC3 17 GLU B 67 CRYST1 99.646 50.752 68.900 90.00 105.34 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010036 0.000000 0.002752 0.00000 SCALE2 0.000000 0.019704 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015050 0.00000